Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 12, 2022 4:30 P.M.
Form: S-3
CIK: 0001840574
Company Name: Verve Therapeutics, Inc.
File Number: 333-265996